Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Transplant Diagnostics Market Poised To Hit $2.96 Billion By 2030 With A 7.1% CAGR#_x000D_
The transplant diagnostics market size has experienced significant expansion in recent years. This market is expected to increase from $2.07 billion in 2025 to $2.25 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.5%. The historical growth trajectory is largely attributable to a rise in organ transplantation procedures, improvements in histocompatibility testing, a growing incidence of immunogenetic disorders, the proliferation of transplant centers, and governmental financial backing for organ donation initiatives._x000D_
_x000D_
The transplant diagnostics market size is anticipated to undergo significant expansion over the next few years. It is projected to increase to $2.96 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. The expected growth during this forecast period stems from the incorporation of AI and machine learning into testing, the embracing of next-generation sequencing (NGS), the broadening scope of personalized immunotherapy, the rise of cloud-based diagnostics platforms, and greater global awareness about organ donation. Significant trends influencing the forecast period encompass rapid histocompatibility testing, AI-powered systems for matching donors and recipients, the integration of molecular diagnostics, advanced high-throughput screening methods, and cloud-based solutions for managing transplant data._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Transplant Diagnostics Market Growth Factors Behind Sustained Expansion#_x000D_
The increasing incidence of chronic diseases is projected to stimulate the growth of the transplant diagnostics market in the coming period. Chronic diseases are enduring health conditions that typically advance slowly, exemplified by diabetes, heart disease, and arthritis, and frequently demand ongoing medical attention and lifestyle modifications to manage symptoms and avert complications. The rise in chronic diseases is largely attributable to unhealthy lifestyle habits, including poor nutrition, lack of physical activity, and smoking, which elevate the risk of developing conditions such as diabetes, heart disease, and obesity. Transplant diagnostics contribute to chronic disease management by enabling precise monitoring of organ health and the timely detection of transplant-related issues. They enhance patient outcomes through guiding prompt interventions, facilitating personalized treatment strategies, and improving long-term organ survival and overall healthcare oversight. For instance, in June 2024, data from the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Thus, the growing prevalence of chronic diseases is a key factor driving the expansion of the transplant diagnostics market._x000D_
_x000D_
#Transplant Diagnostics Market Segment Trends And Revenue Contributors#_x000D_
The transplant diagnostics market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Reagent And Consumables, Instrument, Software And Services _x000D_
2) By Transplant Type: Solid Organ, Stem Cell _x000D_
3) By Organ: Kidney, Liver, Heart, Lung, Pancreas_x000D_
4) By Technology: Non Molecular Assay, Molecular Assay _x000D_
5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers _x000D_
_x000D_
Subsegments:_x000D_
1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials _x000D_
2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers _x000D_
3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services_x000D_
_x000D_
#Transplant Diagnostics Market Industry Trends Fueling Future Revenue Growth#_x000D_
Leading companies in the transplant diagnostics market are concentrating on introducing advanced transplant diagnostics services to maximize their market profits. Advanced transplant diagnostic services involve the utilization of novel and sophisticated diagnostic tools and technologies to enhance the precision and effectiveness of pre-transplant and post-transplant testing. For instance, in March 2023, Quest Diagnostics, a US-based medical laboratory company, unveiled Quest Advanced Specialized Transplant Services, an extensive suite of innovative diagnostics and support solutions designed to improve access to laboratory tests for solid organ, human cell, and tissue transplants. This offering includes a comprehensive selection of more than 170 specialized transplant and infectious disease tests, offers longitudinal trend analysis of test results within the doctor’s electronic medical record (EMR), and provides continuous support services, including medical consultation to ensure appropriate test selection and interpretation of results impacting patient care. These new services build upon Quest’s prior transplant testing offerings by incorporating fresh capabilities. Such capabilities feature new patient-customized information packets aimed at educating patients about the process and assisting Quest’s phlebotomists in fast-tracking testing for patients visiting any of Quest’s 2,100 patient service centers. Results for some tests can be acquired within 8–24 hours._x000D_
_x000D_
#Transplant Diagnostics Market Key Participants And Competitive Landscape#_x000D_
Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc _x000D_
_x000D_
#View The Full Transplant Diagnostics Market Report:#_x000D_
_x000D_
#Transplant Diagnostics Market Geographic Analysis: Where Is Demand Accelerating Fastest?#_x000D_
North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.